Search Results - "Chiarucci, K"

The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up by Steinberg, Martin H., McCarthy, William F., Castro, Oswaldo, Ballas, Samir K., Armstrong, F. Danny, Smith, Wally, Ataga, Kenneth, Swerdlow, Paul, Kutlar, Abdullah, DeCastro, Laura, Waclawiw, Myron A.

“…A randomized, controlled clinical trial established the efficacy and safety of short‐term use of hydroxyurea in adult sickle cell anemia. To examine the risks…”
Get full text

Does sleep-disordered breathing contribute to the clinical severity of sickle cell anemia ? by BROOKS, L. J, KOZIOL, S. M, CHIARUCCI, K. M, BERMAN, B. W

“…This research was undertaken to determine whether obstructive sleep apnea (OSA) and/or nocturnal hemoglobin desaturations contribute to the clinical severity…”
Get full text

Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography by Adams, Robert J, McKie, Virgil C, Hsu, Lewis, Files, Beatrice, Vichinsky, Elliott, Pegelow, Charles, Abboud, Miguel, Gallagher, Dianne, Kutlar, Abdullah, Nichols, Fenwick T, Bonds, Duane R, Brambilla, Donald, Woods, Gerald, Olivieri, Nancy, Driscoll, Catherine, Miller, Scott, Wang, Winfred, Hurlett, Anne, Scher, Charles, Berman, Brian, Carl, Elizabeth, Jones, Anne M, Roach, E. Steve, Wright, Elizabeth, Zimmerman, Robert A, Waclawiw, Myron

“…Stroke occurs by the age of 20 in about 11 percent of patients with sickle cell anemia. 1 – 3 The most frequent cause of brain infarction in these patients is…”
Get full text

Self-regulation and assessment approaches for vaso-occlusive pain management for pediatric sickle cell anemia patients by Hall, H, Chiarucci, K, Berman, B

“…An interdisciplinary program with the goal of teaching self-regulation and minimizing excessive narcotic use in the management of vaso-occlusive pain (V-O) in…”
Get more information

Fetal hemoglobin in sickle cell anemia : Determinants of response to hydroxyurea by STEINBERG, M. H, LU, Z.-H, BARTON, F. B, TERRIN, M. L, CHARACHE, S, DOVER, G. J

“…Abstract Hydroxyurea (HU) can increase fetal hemoglobin (HbF) in sickle cell anemia (HbSS). To identify determinants of the HbF response, we studied 150…”
Get full text

Cost‐effectiveness of hydroxyurea in sickle cell anemia by Moore, Richard D., Charache, Samuel, Terrin, Michael L., Barton, Franca B., Ballas, Samir K.

“…The Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH) demonstrated the efficacy of hydroxyurea in reducing the rate of painful crises compared to…”
Get full text

Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent by Charache, Samuel, Barton, Franca B., Moore, Richard D., Terrin, Michael L., Steinberg, Martin H., Dover, George J., Ballas, Samir K., McMahon, Robert P., Castro, Oswaldo, Orringer, Eugene P.

Get full text

Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications by Abdul-Rauf, A, Gauderer, M, Chiarucci, K, Berman, B

“…Central venous access devices (CVAD) have been used with increasing frequency in recent years among pediatric patients. We retrospectively reviewed our…”
Get more information

Absence of antibiotic-resistant Streptococcus pneumoniae pharyngeal colonization in Cleveland children with sickle cell disease by Schricker, M E, Schreiber, J R, Chiarucci, K, Kerman, J, Noe, A, Jacobs, M R, Berman, B

Get more information